Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Journey Medical Corporation’s names, not what it holds today.
Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and 1 in 2023
Applications published
12
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals5
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Journey Medical Corporation its own name
named as the applicant on its applications, in US
0 granted
12 publishedJourney Medical Corporation its own name
US, as the owner printed on each patent
6 granted
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 12, 2024 | 12,138,311 | Topical tetracycline compositions | Pharmaceuticals | Journey Medical Corporation |
| Jan 3, 2023 | 11,542,232 | Process for production of glycopyrronium tosylate | Organic fine chemistry | Journey Medical Corporation |
| Jun 7, 2022 | 11,352,323 | Processes for making, and methods of using, glycopyrronium compounds | Pharmaceuticals | Journey Medical Corporation |
| May 10, 2022 | 11,324,691 | Compositions and methods for treating rosacea and acne | Pharmaceuticals | Journey Medical Corporation |
| Apr 5, 2022 | 11,291,652 | Glycopyrrolate salts | Pharmaceuticals | Journey Medical Corporation |
| Apr 5, 2022 | 11,291,651 | Glycopyrrolate salts | Pharmaceuticals | Journey Medical Corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 28, 2025 | 2025/0269034 | TOPICAL TETRACYCLINE COMPOSITIONS | Pharmaceuticals | Journey Medical Corporation |
| Jun 12, 2025 | 2025/0186395 | GLYCOPYRROLATE SALTS | Pharmaceuticals | Journey Medical Corporation |
| Apr 10, 2025 | 2025/0114379 | COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES | Pharmaceuticals | Journey Medical Corporation |
| Mar 27, 2025 | 2025/0099492 | COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS | Pharmaceuticals | Journey Medical Corporation |
| Mar 6, 2025 | 2025/0073251 | COMPOSITIONS AND METHODS AND USES THEREOF | Pharmaceuticals | Journey Medical Corporation |
| Aug 1, 2024 | 2024/0252648 | COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF | Pharmaceuticals | Journey Medical Corporation |
| Aug 1, 2024 | 2024/0252647 | COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF | Pharmaceuticals | Journey Medical Corporation |
| Nov 2, 2023 | 2023/0346805 | COMPOSITIONS AND METHODS AND USES THEREOF | Pharmaceuticals | Journey Medical Corporation |
| Aug 31, 2023 | 2023/0270760 | COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS | Pharmaceuticals | Journey Medical Corporation |
| Dec 22, 2022 | 2022/0401412 | METHODS FOR PALMAR OR PLANTAR ADMINISTRATION OF PHARMACEUTICAL COMPOSITIONS | Pharmaceuticals | Journey Medical Corporation |
What it applied for, 2024 to 2025: Pharmaceuticals 7.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.